Literature DB >> 15562072

Ventricular fibrillation median frequency may not be useful for monitoring during cardiac arrest treated with endothelin-1 or epinephrine.

Michael Holzer1, Wilhelm Behringer, Fritz Sterz, Julia Kofler, Elisabeth Oschatz, Ernst Schuster, Anton N Laggner.   

Abstract

In this study, we evaluated whether median fibrillation frequency (MF) and mean fibrillation amplitude (AMP) reflect coronary perfusion pressure (CoPP) and predict successful defibrillation. MF, AMP, and CoPP were measured during prolonged ventricular fibrillation (VF) cardiac arrest and resuscitation in pigs. After 5 min of VF, cardiopulmonary resuscitation was started. At 10 min, the pigs received randomly a single dose of endothelin-1 50 mug (n = 7), 100 mug (n = 7), or 200 mug (n = 5), or repeated doses of epinephrine 0.04 mg/kg (n = 6), or saline (n = 6) every 3 min. At 25 min, the pigs were defibrillated to achieve restoration of spontaneous circulation (ROSC). In a nonparametric spectral analysis of the individual MF versus CoPP and AMP versus CoPP curves, we found no link between the different curves in different animals or therapies. No difference was found in MF in pigs with ROSC (n = 8) compared with animals not achieving ROSC (n = 23) immediately before defibrillation (P = 0.85). Our data suggest that, in prolonged VF cardiac arrest, MF and AMP might not be useful tools to reflect myocardial perfusion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15562072     DOI: 10.1213/01.ANE.0000138421.74434.E3

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

Review 1.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

2.  Reduction of CPR artifacts in the ventricular fibrillation ECG by coherent line removal.

Authors:  Anton Amann; Andreas Klotz; Thomas Niederklapfer; Alexander Kupferthaler; Tobias Werther; Marcus Granegger; Wolfgang Lederer; Michael Baubin; Werner Lingnau
Journal:  Biomed Eng Online       Date:  2010-01-06       Impact factor: 2.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.